Prosight Management as of June 30, 2024
Portfolio Holdings for Prosight Management
Prosight Management holds 46 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Galapagos Nv Spon Adr (GLPG) | 10.0 | $34M | 1.3M | 24.78 | |
| Adc Therapeutics Sa SHS (ADCT) | 9.0 | $30M | 9.6M | 3.16 | |
| Roivant Sciences SHS (ROIV) | 6.3 | $21M | 2.0M | 10.57 | |
| Bridgebio Pharma (BBIO) | 6.1 | $20M | 800k | 25.33 | |
| Zimmer Holdings (ZBH) | 5.5 | $19M | 170k | 108.53 | |
| Meiragtx Holdings (MGTX) | 5.5 | $18M | 4.4M | 4.21 | |
| Shattuck Labs (STTK) | 5.4 | $18M | 4.7M | 3.86 | |
| Kura Oncology (KURA) | 3.9 | $13M | 630k | 20.59 | |
| Cytokinetics Com New (CYTK) | 3.7 | $13M | 230k | 54.18 | |
| Syndax Pharmaceuticals (SNDX) | 3.4 | $11M | 552k | 20.53 | |
| Mirum Pharmaceuticals (MIRM) | 3.2 | $11M | 315k | 34.19 | |
| Kelly Svcs Cl A (KELYA) | 3.2 | $11M | 492k | 21.41 | |
| Zymeworks Del (ZYME) | 3.0 | $10M | 1.2M | 8.51 | |
| Immunovant (IMVT) | 2.6 | $8.6M | 325k | 26.40 | |
| Schrodinger (SDGR) | 2.1 | $7.1M | 369k | 19.34 | |
| Abcellera Biologics (ABCL) | 2.1 | $7.0M | 2.4M | 2.96 | |
| Alkermes SHS (ALKS) | 2.0 | $6.6M | 275k | 24.10 | |
| Erasca (ERAS) | 1.9 | $6.5M | 2.8M | 2.36 | |
| Viking Therapeutics (VKTX) | 1.8 | $6.1M | 115k | 53.01 | |
| Prothena Corp SHS (PRTA) | 1.8 | $5.9M | 287k | 20.64 | |
| Orthopediatrics Corp. (KIDS) | 1.7 | $5.8M | 200k | 28.76 | |
| Option Care Health Com New (OPCH) | 1.7 | $5.7M | 205k | 27.70 | |
| Dex (DXCM) | 1.7 | $5.6M | 49k | 113.38 | |
| Accolade (ACCD) | 1.6 | $5.3M | 1.5M | 3.58 | |
| Cogent Biosciences (COGT) | 1.3 | $4.2M | 500k | 8.43 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $3.7M | 27k | 137.67 | |
| Relay Therapeutics (RLAY) | 0.8 | $2.5M | 385k | 6.52 | |
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $2.5M | 399k | 6.18 | |
| CVS Caremark Corporation (CVS) | 0.7 | $2.4M | 40k | 59.06 | |
| Medtronic SHS (MDT) | 0.7 | $2.4M | 30k | 78.71 | |
| Vincerx Pharma Com New | 0.6 | $2.0M | 2.5M | 0.81 | |
| Inspire Med Sys (INSP) | 0.6 | $1.9M | 14k | 133.83 | |
| Paragon 28 (FNA) | 0.5 | $1.8M | 261k | 6.84 | |
| Universal Hlth Svcs CL B (UHS) | 0.5 | $1.7M | 9.4k | 184.93 | |
| Privia Health Group (PRVA) | 0.5 | $1.7M | 96k | 17.38 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.4 | $1.5M | 476k | 3.14 | |
| Addus Homecare Corp (ADUS) | 0.4 | $1.5M | 13k | 116.11 | |
| Tectonic Therapeutic (TECX) | 0.3 | $1.1M | 68k | 16.47 | |
| Lenz Therapeutics (LENZ) | 0.3 | $1.0M | 60k | 17.29 | |
| 10x Genomics Cl A Com (TXG) | 0.3 | $954k | 49k | 19.45 | |
| Ovid Therapeutics (OVID) | 0.2 | $827k | 1.1M | 0.77 | |
| Immunome (IMNM) | 0.2 | $787k | 65k | 12.10 | |
| Aileron Therapeutics Com New (RNTX) | 0.2 | $734k | 265k | 2.77 | |
| Immuneering Corp Class A Com (IMRX) | 0.2 | $704k | 550k | 1.28 | |
| Biomea Fusion (BMEA) | 0.2 | $560k | 124k | 4.50 | |
| Kezar Life Sciences | 0.0 | $34k | 56k | 0.60 |
